NR3C2 and chronic kidney disease: The rationale for utilizing MRAs to impede the progression from AKI to CKD is supported by the fact that MR inhibition via FIN promotes increased expression of interleukin (IL)-4 receptor in murine kidney IR models, subsequently facilitating the polarization of macrophage toward an M2 phenotype (27).